Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 100 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

11%

11 trials in Phase 3/4

Results Transparency

12%

5 of 42 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

76Total
Not Applicable (50)
Early P 1 (2)
P 1 (9)
P 2 (4)
P 3 (3)
P 4 (8)

Trial Status

Completed42
Recruiting29
Unknown14
Active Not Recruiting8
Not Yet Recruiting4
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 42 completed trials

Clinical Trials (100)

Showing 20 of 20 trials
NCT05909046Not ApplicableRecruiting

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

NCT07197788Not ApplicableEnrolling By Invitation

Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

NCT05603273Not ApplicableCompletedPrimary

Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers

NCT06054035Phase 4RecruitingPrimary

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

NCT05975541Recruiting

Susceptibility to Infectious Diseases in Obesity

NCT05933174Not ApplicableRecruitingPrimary

Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

NCT05654142Not ApplicableActive Not Recruiting

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older

NCT07310849Not ApplicableRecruitingPrimary

Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity

NCT06596330Not ApplicableWithdrawnPrimary

Integration of a Trained Language Model to Improve Glycemic Control With the My Heart Counts Smartphone App

NCT05553912Not ApplicableCompletedPrimary

QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.

NCT06267391Not ApplicableActive Not Recruiting

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

NCT06364644Not ApplicableRecruitingPrimary

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

NCT06263348Phase 4CompletedPrimary

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

NCT05947916Not ApplicableRecruitingPrimary

Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy

NCT07197775Enrolling By Invitation

Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

NCT05662462Not ApplicableRecruiting

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

NCT06292962Not ApplicableCompleted

Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled Trial

NCT06469437Not ApplicableRecruitingPrimary

The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

NCT05499702Phase 2RecruitingPrimary

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

NCT07607015Not Yet Recruiting

CGM Experience, Preferences & Blood Glucose Parameters

Scroll to load more

Research Network

Activity Timeline